Pioglitazone

Product manufactured by Direct Rx

Application Nr Approved Date Route Status External Links
ANDA200268 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Monotherapy And Combination Therapy Pioglitazone Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus In Multiple Clinical Settings [See Clinical Studies (14)]. Important Limitations Of Use Pioglitazone Tablets Exert Its Antihyperglycemic Effect Only In The Presence Of Endogenous Insulin. Pioglitazone Tablets Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. Use Caution In Patients With Liver Disease [See Warnings And Precautions (5.3)].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pioglitazone Hydrochloride PIOGLITAZONE HYDROCHLORIDE ZINC968326

Comments